Susquehanna Portfolio Strategies’s Kinnate Biopharma Inc. Common Stock KNTE Stock Holding History

Susquehanna Portfolio Strategies’s Portfolio KNTE Stock Details KNTE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-48,500	Closed	-$129K	–	778
2024 Q1	$129K	Hold	48,500	–	–	﹤0.01%	760
2023 Q4	$115K	Buy	+48,500	New	+$85.9K	﹤0.01%	969

Susquehanna Portfolio Strategies's KNTE Position: Q2 2024 in Review

Susquehanna Portfolio Strategies sold out of Kinnate Biopharma Inc. Common Stock (KNTE) in Q2 2024, closing a stake of 48,500 shares — an estimated $129K sold.

Susquehanna Portfolio Strategies first reported a position in KNTE in Q4 2023 and held it in 2 quarters. The position peaked at $129K in Q1 2024. 0 funds tracked by Wall St. Rank hold KNTE as of Q2 2024.

Susquehanna Portfolio Strategies reported no remaining Kinnate Biopharma Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Susquehanna Portfolio Strategies sold 48,500 Kinnate Biopharma Inc. Common Stock shares in Q2 2024, an estimated $129K.
Susquehanna Portfolio Strategies first reported a position in Kinnate Biopharma Inc. Common Stock in Q4 2023 and held it in 2 quarters.
Susquehanna Portfolio Strategies's Kinnate Biopharma Inc. Common Stock position peaked at $129K in Q1 2024.
0 funds tracked by Wall St. Rank held Kinnate Biopharma Inc. Common Stock as of Q2 2024.

Based on Susquehanna Portfolio Strategies's 13F filing for Q2 2024, filed 15 Aug 2024.